U.S. FDA Commissioner Says Agency Seeks Fast Review of COVID-19 Products
1 min read
U.S. FDA Commissioner Says Agency Seeks Fast Review of COVID-19 Products
The U.S. Food and Drug Administration is seeking to review treatments and tests for COVID-19 “as fast as we can” for emergency clearance, with the priority on those using high-level science, the agency’s commissioner said on Wednesday.